Lonza envisions five new plants at Visp for modular manufacturing biz
Lonza has started work on a facility to house its new modular tech-based biomanufacturing service at its site in Visp, Switzerland.
Archives for July 27, 2017
NEWS IN BRIEF
Astellas cuts ADCs in California
Tokyo, Japan-headquartered Astellas Pharma is reducing its antibody-drug conjugate R&D activities by shutting a site in California, US.
Pall: ‘More than ever, process control is a core focus area’
Pall Corporation has developed a control system for its single-use benchtop bioreactor and says it will continue to invest in-house for process control technologies.
Roche offsetting biosimilar competition with 16 breakthrough therapies
Roche is confident its biologics pipeline and plan to reformulate some of its top selling monoclonal antibodies can offset sales erosion resulting from biosimilar competition.
Alexion ends Moderna mRNA pact
Alexion Pharmaceuticals says it is reducing R&D operations and terminating mRNA-focused preclinical partnerships.